Mar 11, 2022, 14:04 by

Mar 11, 2022, 14:04 by

Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering as a result of recent acquisitions and its ongoing commitment to the in vitro diagnostics (IVD) industry.

Mar 11, 2022, 14:04 by

Leica Microsystems has announced a new Mica imaging platform bringing previously inaccessible experiments to all life science researchers.

Mar 11, 2022, 14:04 by

Mar 11, 2022, 14:04 by

Lonza has expanded its renowned human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a critical and rapidly expanding market need

Mar 11, 2022, 14:04 by

UK Regulator Cites CluePoints’ Solutions in Updated Guidance MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions.

Mar 11, 2022, 14:04 by

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los Angeles, California.

Mar 11, 2022, 14:04 by

First Databank makes industry-changing announcement at HIMSS22

Mar 11, 2022, 14:04 by

Mar 11, 2022, 14:04 by

Mar 11, 2022, 14:04 by

Molecular Health has collaborated to announce the publication of a triad of articles that demonstrates the concept of a novel systems approach to elucidate the molecular mechanisms of drug toxicities using real-world data (RWD).

Mar 11, 2022, 14:04 by

Mar 11, 2022, 14:04 by

Mar 11, 2022, 14:04 by

Mar 9, 2022, 12:06 by User Not Found

Clinical Research News | A fully remote randomized clinical trial, born of necessity in the early days of the pandemic, provides evidence that the study model is viable even when testing drugs with potential heart rhythm effects. Whether the concept will be as well embraced post-pandemic remains anyone’s guess.

Mar 7, 2022, 01:00 by User Not Found

Clinical Research News | The development and validation of novel digital endpoints in clinical trials was the subject of several case studies shared at the recent Summit for Clinical Ops Executives (SCOPE), including a pilot study of a speech-language assessment tool by Regeneron Pharmaceuticals and trials of at-home monitoring devices for gait speed and nocturnal scratching by Pfizer. Rapid adoption of wearables has provided opportunities to innovate and better understand patients and biomarkers of health abnormalities

Mar 2, 2022, 14:44 by User Not Found

Clinical Research News | A first-in-class myeloid checkpoint inhibitor was granted fast track designation, clinical trial results are in for vagus nerve stimulation to treat heart failure, a clinical trial launches to assess glycosaminoglycan profiling as all-cancer detection method, and new agreements have been entered or extended to promote decentralized trials and the use of digital twins

Mar 1, 2022, 01:00 by User Not Found

Clinical Research News | The current regulatory landscape for decentralized clinical trials (DCTs), and a trio of use cases focused on medical devices and in vitro diagnostic (IVD) products, were among a bevy of presentations on the decentralized study model at the recent Summit for Clinical Research Ops Executives (SCOPE).

Feb 28, 2022, 11:49 by User Not Found

Clinical Research News | New pharma-focused venture cap fund, funding to drive trials for treating immunological and inflammatory diseases and shingles, and more.

Feb 25, 2022, 01:00 by User Not Found

Clinical Research News | Takeda Pharmaceuticals is implementing a “digital visit testing site” for clinical trials, using internal volunteers to test-drive devices in a sandbox environment simulating real-world study conditions prior to their actual deployment. It’s an element of the company’s just-in-time software builds that kick off this month in “proactive preparation for the future.”